Delivery Order SPE2DB20D2014-SPE2DB24FC40B

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,346.96, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication, to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, valued at $3,004.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to DLA facilities supporting the Department of Defense (DoD) worldwide. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $17,117.87 and runs through September 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $13,489.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department...
This federal contract award, with a ceiling value of $3,551.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The award, which does not have a set-aside designation, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award, valued at $1,922.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,451.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $7,477.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,773.64 firm fixed price contract has a completion date of May 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award, valued at $1,977.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to DLA facilities...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC40B
    Delivery Order

This federal contract award, valued at $3,029.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription pharmaceutical product, to support DLA facilities and the Department of Defense (DoD) healthcare system.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to the DLA and DoD. This contract award is not set-aside and was made on a full and open competition basis, highlighting Amerisourcebergen's strong competitive position in the federal pharmaceutical supply market. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/4/24, 9:02 AM